These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2306475)

  • 1. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory action of hydralazine on catecholamine-synthesizing enzymes prepared from bovine adrenal medulla.
    Morita K; Houchi H; Nakanishi A; Minakuchi K; Oka M
    Jpn J Pharmacol; 1986 Mar; 40(3):445-53. PubMed ID: 2872354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of dopamine beta-hydroxylase by beta-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide.
    DeWolf WE; Chambers PA; Southan C; Saunders D; Kruse LI
    Biochemistry; 1989 May; 28(9):3833-42. PubMed ID: 2751998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine-beta-hydroxylase, A copper enzyme, by bleomycin.
    Matsui H; Kato T; Yamamoto C; Takita T; Takeuchi T; Umezawa H; Nagatsu T
    J Antibiot (Tokyo); 1980 Apr; 33(4):435-40. PubMed ID: 6157665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate substrates of dopamine beta-hydroxylase. III. Stoichiometry of the inactivation reaction with benzyl cyanides and spectroscopic investigations.
    Colombo G; Rajashekhar B; Ash DE; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1607-15. PubMed ID: 6319404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence studies on dopamine beta-monooxygenase: effects of salts, pH changes, metal-chelating agents and Cu2+.
    Syvertsen C; Melø TB; Ljones T
    Biochim Biophys Acta; 1987 Jul; 914(1):6-18. PubMed ID: 3607062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
    Fitzpatrick PF; Harpel MR; Villafranca JJ
    Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of avian dopamine beta-hydroxylase.
    Long RA; Weppelman RM; Taylor JE; Tolman RL; Olson G
    Biochemistry; 1981 Dec; 20(26):7423-31. PubMed ID: 7326235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase.
    Kruse LI; DeWolf WE; Chambers PA; Goodhart PJ
    Biochemistry; 1986 Nov; 25(23):7271-8. PubMed ID: 3801416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine beta-hydroxylase. Inactivation by a suicide substrate.
    Baldoni JM; Villafranca JJ
    J Biol Chem; 1980 Oct; 255(19):8987-90. PubMed ID: 7410403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbate 2-sulfate inhibits dopamine beta-hydroxylase reaction, but not ascorbate oxidase reaction.
    Hatanaka H; Egami F; Kato T; Nagatsu T
    J Biochem; 1975 Oct; 78(4):821-4. PubMed ID: 1240099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acetylenic mechanism-based inhibitor of dopamine beta-hydroxylase.
    Colombo G; Villafranca JJ
    J Biol Chem; 1984 Dec; 259(24):15017-20. PubMed ID: 6511785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.